207 related articles for article (PubMed ID: 20858858)
1. Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease.
Xiao W; Ando T; Wang HY; Kawakami Y; Kawakami T
Blood; 2010 Dec; 116(26):6003-13. PubMed ID: 20858858
[TBL] [Abstract][Full Text] [Related]
2. Short Stat5-interacting peptide derived from phospholipase C-β3 inhibits hematopoietic cell proliferation and myeloid differentiation.
Yasudo H; Ando T; Xiao W; Kawakami Y; Kawakami T
PLoS One; 2011; 6(9):e24995. PubMed ID: 21949826
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
Xiao W; Hong H; Kawakami Y; Kato Y; Wu D; Yasudo H; Kimura A; Kubagawa H; Bertoli LF; Davis RS; Chau LA; Madrenas J; Hsia CC; Xenocostas A; Kipps TJ; Hennighausen L; Iwama A; Nakauchi H; Kawakami T
Cancer Cell; 2009 Aug; 16(2):161-71. PubMed ID: 19647226
[TBL] [Abstract][Full Text] [Related]
4. The SPS affair: a complex tale of illicit proliferation.
Braun BS; Shannon K
Cancer Cell; 2009 Aug; 16(2):87-8. PubMed ID: 19647218
[TBL] [Abstract][Full Text] [Related]
5. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
Front Immunol; 2018; 9():1771. PubMed ID: 30116247
[TBL] [Abstract][Full Text] [Related]
6. Direct activation of STAT5 by ETV6-LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis.
Takeda Y; Nakaseko C; Tanaka H; Takeuchi M; Yui M; Saraya A; Miyagi S; Wang C; Tanaka S; Ohwada C; Sakaida E; Yamaguchi N; Yokote K; Hennighausen L; Iwama A
Br J Haematol; 2011 Jun; 153(5):589-98. PubMed ID: 21492125
[TBL] [Abstract][Full Text] [Related]
7. Novel mechanism for Fc{epsilon}RI-mediated signal transducer and activator of transcription 5 (STAT5) tyrosine phosphorylation and the selective influence of STAT5B over mast cell cytokine production.
Pullen NA; Barnstein BO; Falanga YT; Wang Z; Suzuki R; Tamang TD; Khurana MC; Harry EA; Draber P; Bunting KD; Mizuno K; Wilson BS; Ryan JJ
J Biol Chem; 2012 Jan; 287(3):2045-54. PubMed ID: 22130676
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1.
Xiao W; Kashiwakura J; Hong H; Yasudo H; Ando T; Maeda-Yamamoto M; Wu D; Kawakami Y; Kawakami T
Immunity; 2011 Jun; 34(6):893-904. PubMed ID: 21683628
[TBL] [Abstract][Full Text] [Related]
9. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
10. Critical role for mast cell Stat5 activity in skin inflammation.
Ando T; Xiao W; Gao P; Namiranian S; Matsumoto K; Tomimori Y; Hong H; Yamashita H; Kimura M; Kashiwakura J; Hata TR; Izuhara K; Gurish MF; Roers A; Rafaels NM; Barnes KC; Jamora C; Kawakami Y; Kawakami T
Cell Rep; 2014 Jan; 6(2):366-76. PubMed ID: 24412367
[TBL] [Abstract][Full Text] [Related]
11. Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling.
Yu WM; Daino H; Chen J; Bunting KD; Qu CK
J Biol Chem; 2006 Mar; 281(9):5426-34. PubMed ID: 16371368
[TBL] [Abstract][Full Text] [Related]
12. Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.
Sachs Z; Been RA; DeCoursin KJ; Nguyen HT; Mohd Hassan NA; Noble-Orcutt KE; Eckfeldt CE; Pomeroy EJ; Diaz-Flores E; Geurts JL; Diers MD; Hasz DE; Morgan KJ; MacMillan ML; Shannon KM; Largaespada DA; Wiesner SM
Haematologica; 2016 Oct; 101(10):1190-1199. PubMed ID: 27418650
[TBL] [Abstract][Full Text] [Related]
13. The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cells.
Somani AK; Yuen K; Xu F; Zhang J; Branch DR; Siminovitch KA
J Biol Chem; 2001 Jan; 276(3):1938-44. PubMed ID: 11042209
[TBL] [Abstract][Full Text] [Related]
14. Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5.
Xiao W; Hong H; Kawakami Y; Lowell CA; Kawakami T
J Clin Invest; 2008 Mar; 118(3):924-34. PubMed ID: 18246197
[TBL] [Abstract][Full Text] [Related]
15. A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival.
Chen J; Yu WM; Bunting KD; Qu CK
Oncogene; 2004 Apr; 23(20):3659-69. PubMed ID: 15116097
[TBL] [Abstract][Full Text] [Related]
16. Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD.
Okamoto M; Hayakawa F; Miyata Y; Watamoto K; Emi N; Abe A; Kiyoi H; Towatari M; Naoe T
Leukemia; 2007 Mar; 21(3):403-10. PubMed ID: 17230226
[TBL] [Abstract][Full Text] [Related]
17. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
18. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
19. Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD.
Rocnik JL; Okabe R; Yu JC; Lee BH; Giese N; Schenkein DP; Gilliland DG
Blood; 2006 Aug; 108(4):1339-45. PubMed ID: 16627759
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
